Skip to main content

Find Clinical Trials

Home
Conditions
Nervous System Neoplasms

Clinical trial condition

Nervous System Neoplasms

Explore clinical trials studying Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

2,889 public trials 686 recruiting studies

Refine in advanced search Browse all conditions

Nervous System Neoplasms trial results

Completed

Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention

NCT06168825

Conditions: Acceptance and Commitment Therapy, Blood Cancer, Brain Cancer, +57 more
Locations: Howard University Cancer Center Washington D.C., District of Columbia, United States

Inova Life With Cancer Fairfax, Virginia, United States

View Trial Details

Completed

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

NCT05131815

Conditions: Astrocytoma, Behavior, Blood Protein Disorders, +92 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

View Trial Details

Completed

BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors

NCT01957735

Conditions: Brain Diseases, Brain Neoplasms, Cancer, +19 more
Locations: Palo Alto Medical Foundation Sunnyvale, California, United States

Weill Cornell Solid Tumor Oncology Practice New York, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Longitudinal Study of Biomarkers

NCT01595126

Conditions: Central Nervous System Neoplasms, Central Nervous System Tumor, Neoplasms, +3 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Completed

NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma

NCT01894061

Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations: University of Cincinnati Cincinnati, Ohio, United States

University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer

NCT03654716

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumor, +16 more
Locations: UCSF Benioff Children's Hospital San Francisco, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

Texas Children's Hospital, Baylor College of Medicine Houston, Texas, United States

View Trial Details

Completed

Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors

NCT04023669

Conditions: Brain Cancer, Brain Diseases, Brain Neoplasms, +27 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

NCT05021328

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +6 more
Locations: Hubei Cancer Hospital Wuhan, Hubei, China

View Trial Details

Completed

Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

NCT03213691

Conditions: Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma, +29 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Banner Children's at Desert Mesa, Arizona, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

View all 110 locations

View Trial Details

Completed

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

NCT03150862

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: Center For Neurosciences Tucson, Arizona, United States

UCLA Los Angeles, California, United States

University of California At San Francisco San Francisco, California, United States

Sarah Cannon Research Institute (Scri) At Health One Denver, Colorado, United States

View all 22 locations

View Trial Details